hatchwaxman act

0:00:58

Brian Malkin discusses some differences in orphan drug regulations in us vs europe

0:17:09

The Hatch Waxman Act with reference to generic Drugs, The Orange book

0:07:34

Markman Minute: Unions Enter Pharma Patent Fray

0:04:19

Hatch Waxman Litigation CLE: Evolving Legal Framework

0:07:01

The Hatch-Waxman Act | Patent and Exclusivity | Drug Regulatory Affairs

0:52:07

Henry Waxman - The Hatch-Waxman Act and a Life In Congress

0:10:45

2. The Hatch Waxman Act with reference to generic Drugs, The Orange book

0:03:05

Explanation of How Citizen Petitions and ANDAs are Handled by the FDA

0:11:56

Part 1: Axinn Patent Attorneys Discuss Insulins Under the BPCIA vs Hatch-Waxman

0:01:24

Hatch-Waxman Minute: Best Practices for Analyzing the Paragraph IV Letter

0:01:27

Federal Circuit Finds Teva Liable for Induced Infringement

0:13:47

03. The Hatch Waxman Act with reference to generic Drugs, The Orange book

0:01:05

Hatch-Waxman Minute: How to Retain Documents Once the Paragraph IV Letter is Received

1:24:03

Petrie-Flom Center | Assessing the Viability of FDA’s Biosimilar Pathway

0:02:07

Hatch-Waxman Minute: Who Do You Bring Your Complaint Against?

0:03:09

Understanding Patent and Exclusivity

0:01:17

Hatch-Waxman Minute: What to Do When Receiving a Paragraph IV Letter

0:16:56

Orange Book: 101 An Overview (11of27) Generic Drugs Forum 2018

0:11:28

Navigating Orange Book Listings | Finnegan | Podcast

0:26:03

Reining in prescription drug prices: Removing barriers to competition in pharmaceutical markets

0:03:05

Hatch Act

0:53:29

Does Jarkesy Doom the Preserve Access to Affordable Generics and Biosimilars Act?

0:35:55

Reining in prescription drug prices: The politics of prescription drugs

0:53:45

Tom Irving on Litigating 1st Hatch-Waxman Case & Mentoring 1000s in Patent Field